Skip to main content
Tech.euFundingExplorerBeta

TeneoTwo

Exited

New therapy for B-cell hematologic malignancies

TeneoTwo is tracked in the Tech.eu funding database. Based in Delaware, United States; active in Healthtech. Acquired by AstraZeneca in 2022. Data as of Nov 2026.

Delaware, United States
Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—

Funding rounds

0 rounds
No funding rounds recorded.

Exit

Type
acquisition
Date
Jul 2022
Value
€1.2B
Acquiror
AstraZeneca (UK)

Similar companies

same sector, similar size

Global coverage: FundingData